Basit öğe kaydını göster

dc.contributor.authorCekic, Sema Demirci
dc.contributor.authorTasan, Ertugrul
dc.contributor.authorYaylim, Ilhan
dc.contributor.authorMezani, Brunilda
dc.contributor.authorTuran, Saime
dc.contributor.authorErgen, Hayriye Arzu
dc.contributor.authorApak, Mustafa Resat
dc.contributor.authorIlhan, Muzaffer
dc.contributor.authorTurgut, Seda
dc.contributor.authorDursun, Gurbet Korkmaz
dc.contributor.authorKARAMAN, ÖZCAN
dc.date.accessioned2021-03-05T12:02:53Z
dc.date.available2021-03-05T12:02:53Z
dc.date.issued2018
dc.identifier.citationIlhan M., Turgut S., Turan S., Cekic S. D. , Ergen H. A. , Dursun G. K. , Mezani B., KARAMAN Ö., Yaylim I., Apak M. R. , et al., "The assessment of total antioxidant capacity and superoxide dismutase levels, and the possible role of manganese superoxide dismutase polymorphism in acromegaly", ENDOCRINE JOURNAL, cilt.65, ss.91-99, 2018
dc.identifier.issn0918-8959
dc.identifier.othervv_1032021
dc.identifier.otherav_ab2dd154-e131-4137-90af-6ee508f856ff
dc.identifier.urihttp://hdl.handle.net/20.500.12627/114297
dc.identifier.urihttps://doi.org/10.1507/endocrj.ej17-0300
dc.description.abstractOxidative status is attributed to endothelial dysfunction and might be one of the key mechanisms of endothelial dysfunction in acromegaly. In this study, we aimed to investigate the effect of acromegaly on superoxide dismutase (SOD) and total antioxidant capacity (TAC) levels, and the possible influence of human manganese superoxide dismutase (MnSOD) polymorphism on these levels. 51 acromegaly patients and 57 age and sex matched healthy subjects were recruited to the study in Bezmialem Vakif University Hospital between 2011 and 2014. The median SOD and TAC levels were 42.7 (33- 60) pg/mL, and 1,313.7 (155-1,902) mu M in acromegaly; and 46.3 (38-95) pg/mL, and 1,607.3 (195- 1,981) mu M in healthy subjects (p < 0.001, p < 0.001). SOD levels were decreased in controlled and uncontrolled patients compared to healthy subjects (p = 0.05 and p = 0.002, respectively). Controlled and uncontrolled acromegaly displayed significantly decreased levels of TAC compared to healthy subjects (p < 0.05 and p < 0.001, respectively). SOD levels were not associated with MnSOD polymorphisms in acromegaly. In conclusion, this study showed that acromegaly was associated with decreased levels of SOD and TAC, and controlling the disease activity could not adequately improve these levels.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titleThe assessment of total antioxidant capacity and superoxide dismutase levels, and the possible role of manganese superoxide dismutase polymorphism in acromegaly
dc.typeMakale
dc.relation.journalENDOCRINE JOURNAL
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume65
dc.identifier.issue1
dc.identifier.startpage91
dc.identifier.endpage99
dc.contributor.firstauthorID64400


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster